Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Observation
|
Mid-range Performer
2007.0000
2.60
(
0.13
%)
NSE
Sep 23, 2025
15:54 PM
Volume:
454.8K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
04 Aug 2022
US FDA Observation
2007.00
0.13%
Outlook hinges on niche approvals/cost minimization
Neutral:
Lupin Ltd.
by
Motilal Oswal
Target: 610
Target
Motilal Oswal
Lupin Ltd. is trading
above its 150 day SMA
of 1980.4
More from Lupin Ltd.
Recommended
Market closes lower, Tata Motors’ JLR extends production halt till Oct 1
Trendlyne Marketwatch |
23 Sep 2025, 03:57PM
IPO market heats up: 29 new offerings and 8 listings this week
|
22 Sep 2025, 05:34PM
Lupin expects normalization by September quarter
|
17 Apr 2020